Europe Posts Its Best VC Quarter in 4 Years as UK Leads
European startups raised $24 billion in Q2 2026, up two-thirds year-over-year, with UK startups alone pulling in more than $10 billion -- the region's third-largest quarter on record.
Tech IPOs, public-market debuts, and what each one means for the exit environment.
European startups raised $24 billion in Q2 2026, up two-thirds year-over-year, with UK startups alone pulling in more than $10 billion -- the region's third-largest quarter on record.
AEON Biopharma filed a fresh S-1 for a biosimilar program while Mobix Labs amended its filing disclosing a going-concern warning -- a reminder this week's IPO pipeline is mostly small-cap, not AI infrastructure.
Smith Micro Software filed a Form S-1 solely to register the resale of shares underlying previously issued warrants and convertible notes, explicitly stating the filing dilutes no existing shareholders.
Beyond SK Hynix's $28-29 billion Nasdaq debut, this week's US IPO calendar is nearly empty -- a sharp contrast to June's run of SpaceX, Cerebras and Lime, and a sign the pipeline is thinner than headline enthusiasm suggests.
SK Hynix priced its Nasdaq ADS offering at roughly $158 per share on July 9 after a book that was reportedly oversubscribed 7 times, with trading set to begin July 10 under ticker SKHY.
European startups exited $7.2 billion across 172 M&A deals in Q2 2026, with four of the 18 global $1 billion-plus VC-backed acquisitions coming from Europe -- while the region's IPO pipeline stays thin.
Anthropic's $50 billion Series H, split across a ten-investor syndicate plus separate multi-billion tranches from Google and Amazon, shows how mega private rounds are absorbing capital that once would have pushed companies toward an IPO.
A wave of small blank-check filings -- Southern Cross Acquisition II, OceanLight Acquisition and others -- is moving through the SEC this week, even as the large-cap IPO calendar stays nearly empty outside SK Hynix's Nasdaq debut.
Leef Brands, a Vancouver-based cannabis company, filed an S-1 registering more than 81.5 million common shares, joining a wave of smaller companies moving through the SEC pipeline this week.
Wyoming-incorporated Jaovi Inc, based in Costa Rica, filed an S-1 registering 4 million shares at $0.03 each for a total offering of just $120,000 -- illustrating the far end of the small-cap IPO pipeline.
2026's IPO market is really two separate markets: trillion-dollar AI infrastructure debuts stacked against a shakier field of traditional listings -- and only one of those two is actually working.
Standard Nuclear disclosed terms for its NYSE IPO on July 7, offering 18.25 million shares at $18-$21 to raise up to $355.9 million and fund expansion of its domestic nuclear-fuel production.
SK Hynix kicked off bookbuilding for a $28.13 billion Nasdaq ADS offering, with cornerstone investors committing up to $7 billion even as its Seoul-listed shares slid 6.7% on dilution concerns.
Standard Nuclear, an Oak Ridge maker of advanced TRISO reactor fuel with a $245 million backlog, filed for an NYSE IPO under ticker STDN as AI-driven power demand accelerates interest in next-generation nuclear supply chains.
From Agility Robotics to Securitize to Elroy Air, 2026's capital-intensive hardware and infrastructure companies are increasingly choosing SPAC mergers over traditional IPOs to reach public markets faster.
A run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.
SpaceX has already gone public near a $2 trillion valuation, while Anthropic and OpenAI's confidential IPO filings imply valuations of $965 billion and $852 billion, setting up 2026's biggest test of public-market AI pricing.
Bending Spoons' 40% Nasdaq debut pop to a near-$26 billion valuation, alongside fresh European mega-funds like Kembara's, is reviving confidence that Europe can produce IPO-ready tech companies again.
Edge-AI chipmaker Syntiant disclosed a $26.2 million quarterly net loss on $64.5 million in sales ahead of its Nasdaq listing under ticker SYTN, led by Citigroup, Bank of America and UBS.
Securitize completed its SPAC merger with Cantor Equity Partners II and rang the NYSE closing bell on July 6, becoming the first newly public company to tokenize its own stock on Solana and Avalanche on day one.
SK Hynix, the world's second-largest memory chipmaker and a top supplier of AI-GPU memory to Nvidia, filed to list 177.9 million ADSs on Nasdaq under ticker SKHY, seeking up to $29.4 billion in one of the largest offerings on record.
A wave of new S-1 filings this week -- spanning cybersecurity, biotech, medical devices and SPAC vehicles -- shows a broader IPO pipeline building beneath the mega-cap headlines like Agility Robotics and SK Hynix.
Syntiant, an Intel-backed maker of ultra-low-power AI chips for earbuds and cars with over 100 million units deployed, filed for a Nasdaq IPO under ticker SYTN after posting a $20.9 million Q1 net loss on $64.5 million revenue.
Cycurion, which sells AI-driven cybersecurity to the Department of Defense and Homeland Security with an $80 million backlog, filed for a Nasdaq IPO under ticker CYCU after closing a bolt-on Secuvant acquisition.
Agility Robotics' $2.5B SPAC merger tests whether a humanoid robotics company with real warehouse revenue can avoid the boom-bust volatility that has plagued most SPAC-listed companies over the past several cycles.
Agility Robotics is merging with Churchill Capital Corp XI in the largest capital raise in humanoid robotics history, with $300M+ in booked revenue but a CEO who says home robots are still a decade away.
Agility Robotics is going public via SPAC merger at a ~$2.5B valuation, becoming the first pure-play humanoid robotics company to trade publicly, even as its CEO says home robots are a decade away.
Swiss healthcare REIT Infracore and German defense-communications firm Smag are both racing toward July listings, adding to a busier-than-expected European IPO calendar even as broader international indices soften.
Secondary markets are pricing Anthropic's confidential IPO filing at $1.05-$1.15 trillion, a premium over its last private round, as revenue growth accelerates ahead of an October Nasdaq target.
SK Hynix is on track for a tentative July 10 Nasdaq debut targeting roughly $29 billion, which would surpass Alibaba's 2014 New York listing as the largest ADR offering in market history.
OpenAI is reportedly weighing a delay of its IPO to 2027 amid volatile public markets and SpaceX's choppy post-debut trading, a hesitation that could reshape the entire 2026-2027 tech IPO pipeline.
Beyond the SpaceX and Bending Spoons headlines, 2026's tech IPO count is already running about 8% ahead of 2025, with smaller healthcare-data and industrial-tech filers like OneMedNet quietly testing the market.
International IPO indices softened this week even as US listings stayed active, with new SPAC filings targeting AI, quantum computing and Asia-focused deals showing the pipeline still building beneath the volatility.
SpaceX will join the Nasdaq-100 before market open on July 7, just 17 days after its June IPO -- one of the fastest index inclusions on record -- forcing an estimated $4.3B in passive index-fund buying.
IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq July 2 via a SPAC merger with RAAQ at a roughly $1.9 billion valuation, but shares traded below the IPO price for most of the day -- a lukewarm debut IQM's own prospectus.
Jersey Mike's Subs Inc. filed its S-1 for an IPO on July 2, mentioning 'artificial intelligence' or 'AI' 22 times despite being a sandwich-chain franchisor with no AI product offerings, TechCrunch reported the same day.
Hopper agreed to pay $35 million to settle FTC allegations that it used deceptive 'dark patterns' to hide fees and misrepresent the costs and benefits of its 'VIP Support' and 'Price Freeze' services, the agency announced July 2. The settlement follows a pattern of recent FTC crackdowns on hidden-fee practices at Match, StubHub, neobank Dave and Fortnite, and requires Hopper to clearly disclose all fees going forward, though the company says the practices at issue were discontinued in mid-2023, before the FTC's inquiry began.
Scribe Therapeutics filed its S-1 with the SEC on July 2, seeking to list on the Nasdaq Global Market under the ticker 'SCTX.' The clinical-stage biotech, co-founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna, has raised roughly $150 million in equity financing since 2017 and is advancing STX-1150 -- an epigenetic-silencing CRISPR candidate for cardiovascular disease -- through an Australian first-in-human trial, while disclosing only $49.7 million in cash and marketable securities against a $175.1 million accumulated deficit.
Cycurion, a McLean, Virginia-based AI-driven IT cybersecurity and public-sector technology firm, filed a Form S-1 covering nearly 26 million shares for resale, following its completed merger with security services firm Secuvant, which closed June 3, 2026.
Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.
Bending Spoons surged 40% on its Nasdaq debut in the largest software IPO of 2026, then gave back 8.5% the next trading day, underscoring how volatile even a successful AI-era IPO's first week can be.
Crunchbase News reported July 2 that 32 companies went public above a $1 billion valuation in Q2 2026 and 24 more were acquired at $1 billion-plus valuations totaling a record $113 billion, headlined by SpaceX's $1.77 trillion IPO (raising $75 billion) and.
Scribe Therapeutics filed to raise up to $75 million in a Nasdaq IPO, becoming an early test of public-market appetite for Phase 1 biotechs -- its lead candidate, a CRISPR-based epigenetic therapy targeting PCSK9 to lower LDL cholesterol, is already in a.
Lime, the Uber-backed scooter and e-bike rental company, priced its Nasdaq IPO at $25 per share on June 30 — the midpoint of its $24-$26 range — selling 6.96 million shares to raise $174 million at a $1.6 billion valuation. Shares jumped about 9% in their first hour of trading July 1 under ticker LIME, capping years of on-again, off-again public-listing speculation for the micromobility company.
Milan-based Bending Spoons priced its IPO at $29 per share, raised $1.68 billion, and closed its first trading day up 40% at $40.50, pushing its market cap to $25.7 billion -- more than double its prior $11 billion private valuation -- TechCrunch reported.
Bending Spoons priced its Nasdaq IPO at $29 per share on June 30 — above its $26-$28 marketed range — raising $1.68 billion at an $18.4 billion valuation, then closed its first trading day up roughly 40% near $25.7 billion. The Milan-based company, which buys and revitalizes aging tech brands including AOL, Evernote, Meetup and Vimeo, posted $601 million in Q1 revenue and swung to a $27.4 million profit from a $112 million loss a year earlier.
VenHub Global filed an S-1/A amendment on July 1 as it works toward a direct listing on Nasdaq under ticker VNHB, registering up to 15.5 million shares for sale by existing holders rather than raising new capital. The company builds fully autonomous, AI-driven robotic smart stores, has deployed three to date, and carries an accumulated deficit near $98.8 million with auditors flagging substantial going-concern doubt.
Milan-based Bending Spoons priced its Nasdaq IPO at $29 a share on June 30 — above its marketed $26-$28 range — raising $1.68 billion and valuing the company at roughly $18.4 billion. Shares opened at $31 on July 1, touched an intraday high of $42.50, and closed the session at $40.50, up nearly 40%, making it one of the strongest software IPO debuts of 2026 despite a broader SaaS slowdown.
Shared e-bike and scooter operator Lime listed on Nasdaq on July 1, pricing nearly 7 million shares between $24 and $26, becoming one of the first profitable consumer mobility names to test public markets in 2026.
OneMedNet Corporation, a Minnesota-based healthcare data company, filed a Form S-1 on July 1 registering up to 11.68 million shares of common stock, including up to 8.5 million shares issuable under a Standby Equity Purchase Agreement (SEPA) dated the same day. SEPAs let a public company draw down capital incrementally by selling shares to an investor at its own discretion, a financing structure often used by smaller-cap companies that need flexible access to capital without a traditional follow-on offering.
Actelis Networks filed a new Form S-1 with the SEC on July 1, following an earlier registration statement that went effective in November 2025. The Sunnyvale, California-based company sells hybrid fiber-copper-coax networking equipment for IoT, security and telecom deployments, letting customers deploy fast, secure connectivity over existing copper and coaxial infrastructure without a full fiber rebuild.
Asia AI Group Inc filed a Form S-1 with the SEC on July 1, joining a wave of smaller companies filing AI-branded registration statements even as OpenAI, Anthropic and SpaceX dominate IPO headlines with valuations near or above $1 trillion. The filing adds to a growing list of small-cap AI-named S-1s this year, underscoring how far the AI-IPO enthusiasm has spread beyond the handful of marquee frontier labs getting most investor attention.
Freedom Metals Acquisition Corp filed an S-1/A amendment on July 1, detailing a blank-check company structure targeting acquisitions in the critical metals and mining sector. Sponsor NLC America SPAC 1 LLC and underwriter Cohen & Company Capital Markets have committed to purchase private placement units worth up to roughly $9.1 million if the over-allotment option is exercised in full, positioning the SPAC to hunt for a target in a sector newly critical to both AI data-center buildouts and defense supply chains.
Lime — the world's largest shared micromobility operator, formally Neutron Holdings — priced its Nasdaq IPO at the $25 midpoint on June 30 and begins trading July 1 under ticker LIME, raising roughly $174-182M at a $1.63-1.8B market cap. Uber, which owns a meaningful stake and operates Lime bikes and scooters through its ride-hail app, is a key backer testing whether the scooter category still has a public-market future after Bird's bankruptcy.
QumulusAI filed a seventh S-1/A amendment on July 1 ahead of a planned Nasdaq direct listing, detailing an Atlanta-based GPU-as-a-service business built from the 2022 merger of a blockchain-hosting company and a data-center asset firm, later rebranded after acquiring The Cloud Minders in 2025. The company reported $3.4 million in quarterly revenue against a $5.5 million operating loss, is scaling toward 120 megawatts and up to 90,000 Nvidia B200/B300 GPUs, and disclosed going-concern risk in its filing.
Encore Medical filed an amended S-1 on July 1 ahead of a planned NYSE American listing under ticker EMI, offering 3 million shares at an expected $5.00 each to raise roughly $12.6-14.67 million to fund US clinical trials for its catheter-delivered heart-defect closure device, which has completed more than 35,000 implants outside the United States but has not yet been approved for US sale. Underwriters BofA Securities, Goldman Sachs and Morgan Stanley are jointly leading the offering.
Actelis Networks, the Nasdaq-listed hybrid fiber-coax networking company, filed a Form S-1 on July 1 to re-register shares tied to an amended equity line of credit (ELOC) with White Lion Capital, after 10 million of the 10.6 million shares originally registered for the arrangement in October 2025 remained unsold. The amendment registers up to 15.85 million shares across revised ELOC shares, commitment shares and warrant shares — a dilutive financing structure for a cybersecurity-hardened networking equipment maker, rather than a new IPO.
Factorial Energy completed its business combination with Cartesian Growth Corporation III and began trading on Nasdaq under ticker FAC on June 8, implying about $1.3 billion in equity value and delivering over $100 million in gross proceeds to fund commercialization of its solid-state batteries for defense, data centers, drones, robotics and e-mobility. Stellantis holds a 9.5% stake in the combined company, underscoring continued automaker conviction in solid-state battery technology.
Encore Medical, a structural heart device company developing transcatheter septal occlusion products, filed its latest S-1/A on June 30, targeting an IPO of 3 million shares at an expected $5 per share on NYSE American under ticker EMI. The company's cash balance stood at just $34,619 as of March 31, 2026, underscoring how urgently it needs the offering to fund ongoing US clinical trials.
SeeQC, which builds digital quantum-computing infrastructure, filed a Form S-1 to list on the Nasdaq Global Market under ticker 'SEQC,' paired with a $65 million PIPE financing that values the combined entity at roughly $1 billion. The company integrates superconducting single-flux-quantum logic with cryogenic CMOS to shrink the wiring and heat load of quantum systems -- reporting $4.2 million in 2025 revenue against a $12.2 million net loss.